Figure 1. Line chart showing soluble urokinase-type plasminogen activator receptor (suPAR) maximum (median 8.7 ng/ml, range 4.0–18.2 ng/ml) and convalesce phase concentrations (median 4.7 ng/ml, range 2.4–12.2 ng/ml) in relation to the onset of fever (day 0) in 97 patients with Puumala hantavirus infection (P-value for the difference <0.001).

Short title: Line chart showing suPAR maximum and convalescence concentrations in relation to the onset of fever.